{
    "root": "4943687d-dcd5-4f82-947a-50cd8ca60ab2",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "LAMICTAL",
        "suffix": {
            "text": "XR"
        }
    },
    "value": "20250425",
    "ingredients": [
        {
            "name": "LAMOTRIGINE",
            "code": "U3H27498KS"
        },
        {
            "name": "GLYCERYL MONOSTEARATE",
            "code": "230OU9XXE4"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METHACRYLIC ACID",
            "code": "1CS02G8656"
        },
        {
            "name": "Polyethylene glycol 400",
            "code": "B697894SGQ"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "COCHINEAL",
            "code": "TZ8Z31B35M"
        }
    ],
    "indications": "lamictal xr indicated : • adjunctive therapy primary generalized tonic-clonic seizures ( pgtc ) partial-onset seizures without secondary generalization patients aged 13 years older . ( 1.1 ) • conversion monotherapy patients aged 13 years older partial-onset seizures receiving treatment single antiepileptic . ( 1.2 ) limitation : safety effectiveness patients younger 13 years established . ( 1.3 )",
    "contraindications": "lamictal xr extended-release tablets taken daily , without food . tablets must swallowed whole must chewed , crushed , divided .",
    "warningsAndPrecautions": "lamictal xr ( lamotrigine ) extended-release tablets 25-mg , yellow white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 25 ” , unit-of-use bottles 30 orange caps ( ndc 0173-0754-00 ) . 50-mg , green white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 50 ” , unit-of-use bottles 30 orange caps ( ndc 0173-0755-00 ) . 100-mg , orange white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 100 ” , unit-of-use bottles 30 orange caps ( ndc 0173-0756-00 ) . 200-mg , blue white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 200 ” , unit-of-use bottles 30 orange caps ( ndc 0173-0757-00 ) . 250-mg , purple white center , caplet-shaped , film-coated tablets printed one face black ink “ lamictal ” “ xr 250 ” , unit-of-use bottles 30 orange caps ( ndc 0173-0781-00 ) . 300-mg , gray white center , caplet-shaped , film-coated tablets printed one face black ink “ lamictal ” “ xr 300 ” , unit-of-use bottles 30 orange caps ( ndc 0173-0761-00 ) . lamictal xr ( lamotrigine ) patient titration kit patients taking valproate ( blue xr kit ) 25-mg , yellow white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 25 ” 50 mg , green white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 50 ” ; blister pack 21/25-mg tablets 7/50-mg tablets ( ndc 0173-0758-00 ) . lamictal xr ( lamotrigine ) patient titration kit patients taking carbamazepine , phenytoin , phenobarbital , primidone , taking valproate ( green xr kit ) 50-mg , green white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 50 ” ; 100 mg , orange white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 100 ” ; 200 mg , blue white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 200 ” ; blister pack 14/50-mg tablets , 14/100-mg tablets , 7/200-mg tablets ( ndc 0173-0759-00 ) . lamictal xr ( lamotrigine ) patient titration kit patients taking carbamazepine , phenytoin , phenobarbital , primidone , valproate ( orange xr kit ) 25-mg , yellow white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 25 ” ; 50 mg , green white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 50 ” ; 100 mg , orange white center , round , biconvex , film-coated tablets printed one face black ink “ lamictal ” “ xr 100 ” ; blister pack 14/25-mg tablets , 14/50-mg tablets , 7/100-mg tablets ( ndc 0173-0760-00 ) . storage store 25°c ( 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "lamictal xr contraindicated patients demonstrated hypersensitivity ( e.g . , rash , angioedema , acute urticaria , extensive pruritus , mucosal ulceration ) ingredients [ boxed warning , ( 5.1 , 5.3 ) ] .",
    "indications_original": "LAMICTAL XR is indicated for: • adjunctive therapy for primary generalized tonic-clonic seizures (PGTC) and partial-onset seizures with or without secondary generalization in patients aged 13 years and older. ( 1.1 ) • conversion to monotherapy in patients aged 13 years and older with partial-onset seizures who are receiving treatment with a single antiepileptic drug. ( 1.2 ) Limitation of use: Safety and effectiveness in patients younger than 13 years have not been established. ( 1.3 )",
    "contraindications_original": "LAMICTAL XR extended-release tablets are taken once daily, with or without food. Tablets must be swallowed whole and must not be chewed, crushed, or divided.",
    "warningsAndPrecautions_original": "LAMICTAL XR (lamotrigine) extended-release tablets\n                  \n                  25-mg, yellow with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 25”, unit-of-use bottles of 30 with orange caps (NDC 0173-0754-00).\n                  50-mg, green with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 50”, unit-of-use bottles of 30 with orange caps (NDC 0173-0755-00).\n                  100-mg, orange with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 100”, unit-of-use bottles of 30 with orange caps (NDC 0173-0756-00).\n                  200-mg, blue with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 200”, unit-of-use bottles of 30 with orange caps (NDC 0173-0757-00).\n                  250-mg, purple with a white center, caplet-shaped, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 250”, unit-of-use bottles of 30 with orange caps (NDC 0173-0781-00).\n                  300-mg, gray with a white center, caplet-shaped, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 300”, unit-of-use bottles of 30 with orange caps (NDC 0173-0761-00).\n                  \n                     LAMICTAL XR (lamotrigine) Patient Titration Kit for Patients Taking Valproate (Blue XR Kit)\n                  \n                  25-mg, yellow with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 25” and 50 mg, green with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 50”; blister pack of 21/25-mg tablets and 7/50-mg tablets (NDC 0173-0758-00).\n                  \n                     LAMICTAL XR (lamotrigine) Patient Titration Kit for Patients Taking Carbamazepine, Phenytoin, Phenobarbital, or Primidone, and Not Taking Valproate (Green XR Kit)\n                  \n                  50-mg, green with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 50”; 100 mg, orange with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 100”; and 200 mg, blue with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 200”; blister pack of 14/50-mg tablets, 14/100-mg tablets, and 7/200-mg tablets (NDC 0173-0759-00).\n                  \n                     LAMICTAL XR (lamotrigine) Patient Titration Kit for Patients Not Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Valproate (Orange XR Kit)\n                  \n                  25-mg, yellow with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 25”; 50 mg, green with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 50”; and 100 mg, orange with a white center, round, biconvex, film-coated tablets printed on one face in black ink with “LAMICTAL” and “XR 100”; blister pack of 14/25-mg tablets, 14/50-mg tablets, and 7/100-mg tablets (NDC 0173-0760-00).\n                  \n                     Storage\n                  \n                  Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "LAMICTAL XR is contraindicated in patients who have demonstrated hypersensitivity (e.g., rash, angioedema, acute urticaria, extensive pruritus, mucosal ulceration) to the drug or its ingredients [see Boxed Warning, Warnings and Precautions (5.1, 5.3)]."
}